Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rezaie, A. R.
Right arrow Articles by Esmon, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rezaie, A. R.
Right arrow Articles by Esmon, C. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 43, Issue of October 27, 1995 pp. 25336-25339
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Protein C Inhibitor Is a Potent Inhibitor of the Thrombin-Thrombomodulin Complex

(Received for publication, July 14, 1995; and in revised form, August 29, 1995)

Alireza R. Rezaie Scott T. Cooper Frank C. Church Charles T. Esmon

Protein C inhibitor (PCI), a plasma serine protease inhibitor, inhibits several proteases including the anticoagulant enzyme, activated protein C (APC), and the coagulation enzymes, thrombin and factor Xa. Previous studies have shown that thrombin and APC are inhibited at similar rates by PCI and that heparin accelerates PCI inhibition of both enzymes more than 20-fold. We now demonstrate that the thrombin-binding proteoglycan, rabbit thrombomodulin, accelerates inhibition of thrombin by PCI approx140-fold (k(2) = 2.4 times 10^6 in the presence of TM compared to 1.7 times 10^4M s in the absence of TM). Most of this effect is mediated by protein-protein interactions since the active fragment of TM composed of epidermal growth factor-like domains 4-6 (TM 4-6) accelerates inhibition by PCI approx59-fold (k(2) = 1.0 times 10^6M s). The mechanism by which TM alters reactivity with PCI appears to reside in part in an alteration of the S2 specificity pocket. Replacing Phe with Pro at the P2 position in the reactive loop of PCI yields a mutant that inhibits thrombin better in the absence of TM (k(2) = 6.3 times 10^5M s), but TM 4-6 enhances inhibition by this mutant approx9-fold (k(2) = 5.8 times 10^6M s) indicating that TM alleviates the inhibitory effect of the less favored Phe residue. These results indicate that PCI is a potent inhibitor of the protein C anticoagulant pathway at the levels of both zymogen activation and enzyme inhibition.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W. Li and J. A. Huntington
The Heparin Binding Site of Protein C Inhibitor Is Protease-dependent
J. Biol. Chem., December 19, 2008; 283(51): 36039 - 36045.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Sun, S. Parry, M. Panico, H. R. Morris, M. Kjellberg, A. Engstrom, A. Dell, and S. Schedin-Weiss
N-Glycans and the N Terminus of Protein C Inhibitor Affect the Cofactor-enhanced Rates of Thrombin Inhibition
J. Biol. Chem., July 4, 2008; 283(27): 18601 - 18611.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex
PNAS, March 25, 2008; 105(12): 4661 - 4666.



Home page
GutHome page
T Hamada, H Kamada, T Hayashi, J Nishioka, E C Gabazza, S Isaji, S Uemoto, and K Suzuki
Protein C inhibitor regulates hepatocyte growth factor activator-mediated liver regeneration in mice
Gut, March 1, 2008; 57(3): 365 - 373.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Li, T. E. Adams, M. Kjellberg, J. Stenflo, and J. A. Huntington
Structure of Native Protein C Inhibitor Provides Insight into Its Multiple Functions
J. Biol. Chem., May 4, 2007; 282(18): 13759 - 13768.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M.-C. Bouton, L. Venisse, B. Richard, C. Pouzet, V. Arocas, and M. Jandrot-Perrus
Protease Nexin-1 Interacts With Thrombomodulin and Modulates Its Anticoagulant Effect
Circ. Res., April 27, 2007; 100(8): 1174 - 1181.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. O. Mosnier and B. N. Bouma
Regulation of Fibrinolysis by Thrombin Activatable Fibrinolysis Inhibitor, an Unstable Carboxypeptidase B That Unites the Pathways of Coagulation and Fibrinolysis
Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2445 - 2453.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
M. D. Anway, M. D. Show, and B. R. Zirkin
Protein C Inhibitor Expression by Adult Rat Sertoli Cells: Effects of Testosterone Withdrawal and Replacement
J Androl, September 1, 2005; 26(5): 578 - 585.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Ludeman, H. Kataoka, Y. Srinivasan, N. L. Esmon, C. T. Esmon, and S. R. Coughlin
PAR1 Cleavage and Signaling in Response to Activated Protein C and Thrombin
J. Biol. Chem., April 1, 2005; 280(13): 13122 - 13128.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yang, C. Manithody, T. D. Walston, S. T. Cooper, and A. R. Rezaie
Thrombomodulin Enhances the Reactivity of Thrombin with Protein C Inhibitor by Providing Both a Binding Site for the Serpin and Allosterically Modulating the Activity of Thrombin
J. Biol. Chem., September 26, 2003; 278(39): 37465 - 37470.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. T. Esmon
The Protein C Pathway
Chest, September 1, 2003; 124(3_suppl): 26S - 32S.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
C. T. Esmon
Coagulation and inflammation
Innate Immunity, June 1, 2003; 9(3): 192 - 198.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
D. Palmieri, J. W. Lee, R. L. Juliano, and F. C. Church
Plasminogen Activator Inhibitor-1 and -3 Increase Cell Adhesion and Motility of MDA-MB-435 Breast Cancer Cells
J. Biol. Chem., October 18, 2002; 277(43): 40950 - 40957.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. T. Esmon
New Mechanisms for Vascular Control of Inflammation Mediated by Natural Anticoagulant Proteins
J. Exp. Med., September 2, 2002; 196(5): 561 - 564.
[Full Text] [PDF]


Home page
BloodHome page
F. B. Taylor Jr, G. T. Peer, M. S. Lockhart, G. Ferrell, and C. T. Esmon
Endothelial cell protein C receptor plays an important role in protein C activation in vivo
Blood, March 15, 2001; 97(6): 1685 - 1688.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Han, R. Fiehler, and G. J. Broze Jr
Characterization of the protein Z-dependent protease inhibitor
Blood, November 1, 2000; 96(9): 3049 - 3055.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-E. Marque, R. Spuntarelli, L. Juliano, M. Aiach, and B. F. Le Bonniec
The Role of Glu192 in the Allosteric Control of the S2' and S3' Subsites of Thrombin
J. Biol. Chem., January 14, 2000; 275(2): 809 - 816.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. J. Prendes, E. Bielek, M. Zechmeister-Machhart, E. Vanyek-Zavadil, V. A. Carroll, J. Breuss, B. R. Binder, and M. Geiger
Synthesis and Ultrastructural Localization of Protein C Inhibitor in Human Platelets and Megakaryocytes
Blood, August 15, 1999; 94(4): 1300 - 1312.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. R. Lentz, J. A. Fernandez, J. H. Griffin, D. J. Piegors, R. A. Erger, M. R. Malinow, and D. D. Heistad
Impaired Anticoagulant Response to Infusion of Thrombin in Atherosclerotic Monkeys Associated With Acquired Defects in the Protein C System
Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1744 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. He, Y.-L. Lin, and Y.-X. Liu
Functionally inactive protein C inhibitor in seminal plasma may be associated with infertility
Mol. Hum. Reprod., June 1, 1999; 5(6): 513 - 519.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. F. Macko, L. A. Killewich, J. A. Fernandez, D. K. Cox, A. Gruber, and J. H. Griffin
Brain-Specific Protein C Activation During Carotid Artery Occlusion in Humans
Stroke, March 1, 1999; 30(3): 542 - 545.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Rezaie
Calcium Enhances Heparin Catalysis of the Antithrombin-Factor Xa Reaction by a Template Mechanism. EVIDENCE THAT CALCIUM ALLEVIATES Gla DOMAIN ANTAGONISM OF HEPARIN BINDING TO FACTOR Xa
J. Biol. Chem., July 3, 1998; 273(27): 16824 - 16827.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Nishioka, M. Ning, T. Hayashi, and K. Suzuki
Protein C Inhibitor Secreted from Activated Platelets Efficiently Inhibits Activated Protein C on Phosphatidylethanolamine of Platelet Membrane and Microvesicles
J. Biol. Chem., May 1, 1998; 273(18): 11281 - 11287.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. G.L.M. Elisen, P. A.Kr. von dem Borne, B. N. Bouma, and J. C.M. Meijers
Protein C Inhibitor Acts as a Procoagulant by Inhibiting the Thrombomodulin-Induced Activation of Protein C in Human Plasma
Blood, March 1, 1998; 91(5): 1542 - 1547.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Laszik, A. Mitro, F. B. Taylor Jr, G. Ferrell, and C. T. Esmon
Human Protein C Receptor Is Present Primarily on Endothelium of Large Blood Vessels : Implications for the Control of the Protein C Pathway
Circulation, November 18, 1997; 96(10): 3633 - 3640.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. A. Carroll, M. R. Griffiths, M. Geiger, C. Merlo, M. Furlan, B. Lammle, and B. R. Binder
Plasma Protein C Inhibitor Is Elevated in Survivors of Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 114 - 118.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. R. Rezaie and A. R. Rezaie
Role of Residue 99at the S2 Subsite of Factor Xa and Activated Protein C in Enzyme Specificity
J. Biol. Chem., September 27, 1996; 271(39): 23807 - 23814.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Regan, D. J. Stearns-Kurosawa, S. Kurosawa, J. Mollica, K. Fukudome, and C. T. Esmon
The Endothelial Cell Protein C Receptor. INHIBITION OF ACTIVATED PROTEIN C ANTICOAGULANT FUNCTION WITHOUT MODULATION OF REACTION WITH PROTEINASE INHIBITORS
J. Biol. Chem., July 19, 1996; 271(29): 17499 - 17503.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
S. T. Cooper, L. L. Neese, M. N. DiCuccio, D. K. Liles, M. Hoffman, and F. C. Church
Vascular Localization of the Heparin-binding Serpins Antithrombin, Heparin Cofactor II, and Protein C Inhibitor
Clinical and Applied Thrombosis/Hemostasis, July 1, 1996; 2(3): 185 - 191.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement